Status and phase
Conditions
Treatments
About
The purpose of the study is to assess efficacy, safety and tolerability of 2 dose regimens of certolizumab pegol
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
0 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal